20d
Clinical Trials Arena on MSNTrevi’s Phase IIb chronic cough success spikes stock by 71%The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.
ANSWER: Although most people think that asthma causes wheezing, cough is a very common symptom of asthma. You’ve named the ...
As GP Dr Ahmed recently shared in a TikTok video, he’s seeing patient after patient with an ongoing cough at the moment. “I ...
(WPVI) -- A cough is supposed to protect the lungs and windpipe from irritants. But coughs that go on and on can be annoying - or signs of bigger problems. Chronic coughs can have many causes and ...
Additional symptoms can include a chronic cough that can be dry or may produce mucus; shortness of breath; a sensation of ...
Trevi Therapeutics posted a wider loss in the fourth quarter as it increased spending on trials for chronic cough treatments. The biopharmaceutical company posted a loss of $11.4 million, or 11 cents ...
Refractory chronic cough is a cough that persists for over 8 weeks and does not respond to treatment of any underlying cause. Recent randomised trials for refractory chronic cough have shown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results